US Patent Issued to KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY on July 14 for "Human induced pluripotent stem cell line transformed with fluorescent protein-labeled cytochrome P450 and AHR modulator screening method using same" (South Korean Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,680,081, issued on July 14, was assigned to KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (Daejeon, South Korea).

"Human induced pluripotent stem cell line transformed with fluorescent protein-labeled cytochrome P450 and AHR modulator screening method using same" was invented by Han-Jin Park (Daejeon, South Korea), Ji-Woo Kim (Daejeon, South Korea), Ilkyun Im (Daejeon, South Korea) and Hyemin Kim (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a human induced pluripotent stem cell line transformed with fluorescent protein-tagged CYP1A1 and an AHR modulator screening method using the same. Specifica...